Compass Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Compass Financial Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,407	Closed	-$1.35M	–	6
2023 Q1	$1.35M	Sell	19,407 -1,093	-5%	-$77.1K	1.71%	11
2022 Q4	$1.47M	Sell	20,500 -417	-2%	-$31.4K	1.99%	8
2022 Q3	$1.49M	Buy	20,917 +15	+0.1%	+$1.09K	2.21%	7
2022 Q2	$1.61M	Sell	20,902 -530	-2%	-$40.4K	2.19%	6
2022 Q1	$1.56M	Buy	21,432 +368	+2%	+$24.7K	1.73%	9
2021 Q4	$1.31M	Buy	+21,064	New	+$1.24M	1.45%	13

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Compass Financial Advisors's BMY Position: Q2 2023 in Review

Compass Financial Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 19,407 shares — an estimated $1.35M sold.

Compass Financial Advisors first reported a position in BMY in Q4 2021 and held it in 6 quarters. The position peaked at $1.61M in Q2 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Compass Financial Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Compass Financial Advisors sold 19,407 Bristol-Myers Squibb shares in Q2 2023, an estimated $1.35M.
Compass Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 6 quarters.
Compass Financial Advisors's Bristol-Myers Squibb position peaked at $1.61M in Q2 2022.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Compass Financial Advisors's 13F filing for Q2 2023.